NW
ABBV icon

NewEdge Wealth’s AbbVie ABBV Stock Holding History

NewEdge Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Buy
422,116
+16,054
+4% +$3.45M 1.06% 17
2026
Q1 		$88.3M Buy
406,062
+8,385
+2% +$1.86M 1.05% 15
2025
Q4 		$90.9M Buy
397,677
+93,155
+31% +$21.2M 1.03% 16
2025
Q3 		$66M Buy
304,522
+75,364
+33% +$15.3M 0.95% 17
2025
Q2 		$45.6M Buy
229,158
+16,606
+8% +$3.09M 0.71% 28
2025
Q1 		$44.5M Buy
212,552
+9,428
+5% +$1.83M 0.81% 27
2024
Q4 		$36.1M Buy
203,124
+14,422
+8% +$2.65M 0.63% 37
2024
Q3 		$37.3M Buy
188,702
+73,358
+64% +$13.7M 0.67% 35
2024
Q2 		$19.8M Buy
115,344
+71,123
+161% +$11.8M 0.43% 62
2024
Q1 		$7.11M Sell
44,221
-2,164
-5% -$373K 0.16% 129
2023
Q4 		$7.19M Sell
46,385
-40,992
-47% -$5.98M 0.18% 121
2023
Q3 		$13M Buy
87,377
+8,675
+11% +$1.27M 0.41% 72
2023
Q2 		$10.6M Buy
78,702
+12,823
+19% +$1.88M 0.35% 82
2023
Q1 		$10.5M Buy
65,879
+1,739
+3% +$266K 0.4% 75
2022
Q4 		$10.4M Buy
64,140
+6,036
+10% +$926K 0.45% 62
2022
Q3 		$7.8M Buy
58,104
+59
+0.1% +$8.47K 0.37% 79
2022
Q2 		$8.89M Buy
58,045
+24,066
+71% +$3.68M 0.4% 70
2022
Q1 		$5.51M Buy
33,979
+30,981
+1,033% +$4.5M 0.24% 102
2021
Q4 		$406K Buy
2,998
+599
+25% +$70.8K 0.02% 314
2021
Q3 		$259K Buy
2,399
+79
+3% +$9.03K 0.02% 259
2021
Q2 		$261K Buy
+2,320
New +$261K 0.02% 254

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NewEdge Wealth's ABBV Position: Q2 2026 in Review

NewEdge Wealth increased its AbbVie (ABBV) stake by 4% in Q2 2026, buying an estimated $3.45M and bringing the position to 422,116 shares worth $106M. The position accounts for 1.06% of the portfolio, ranked #17.

NewEdge Wealth first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • NewEdge Wealth held 422,116 shares of AbbVie worth $106M as of Q2 2026.
  • NewEdge Wealth bought 16,054 AbbVie shares in Q2 2026, an estimated $3.45M.
  • AbbVie made up 1.06% of NewEdge Wealth's portfolio in Q2 2026, its #17 holding.
  • NewEdge Wealth first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.